CLINICAL_TRIALS
trial_result
· 2015-10-15
Clinical Trial Update: Electroconvulsive Therapy in Clozapine Refractory Schizophrenia [Phase 1, Phase 2]
Summary
A Phase 1/2 trial evaluates electroconvulsive therapy for schizophrenia patients refractory to clozapine, with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwell Health | Conditions: Schizophrenia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-10-15